Zobrazeno 1 - 10
of 66
pro vyhledávání: '"R, Bouhass"'
Autor:
N. Hakiki, Kamila Amani, H. Ouldjeriouat, Mohamed Brahimi, Leila Charef, F. Bouamama, B. Mansour, Mohamed Amine Bekadja, Soufi Osmani, Abdessamed Arabi, R. Bouhass, Nabil Yafour, Badra Entasoltan, Samira Bouchama
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 60(3)
Mobilization failure in patients is a major therapeutic concern which makes subsequent ASCT impossible. A new growth factor called Plerixafor (Mozobil®) developed by the pharmaceutical industry (Sanofi-aventis, France), is a chemoreceptor antagonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9eaaf96077e73538f46d662e220e10
https://pubmed.ncbi.nlm.nih.gov/33612450
https://pubmed.ncbi.nlm.nih.gov/33612450
Autor:
Mohamed Amine Bekadja, Faiza Serradj, Mohamed Brahimi, R. Bouhass, Soufi Osmani, Nabil Yafour, Ali Bazarbachi, Abdessamad Arabi
Publikováno v:
Current research in translational medicine. 68(4)
Current Research in Translational Medicine - Sous presse. Epreuves corrigees par l'auteur. Disponible en ligne depuis le lundi 5 octobre 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb851eebd97c121566a8ca225629cea
https://pubmed.ncbi.nlm.nih.gov/33028507
https://pubmed.ncbi.nlm.nih.gov/33028507
Autor:
Mohamed Amine Bekadja, Amina Krim, Faiza Serradj, Kamila Amani, Nabil Yafour, R. Bouhass, Soufi Osmani, Mohamed Brahimi, Souad Talhi
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 10, Iss 4, Pp 311-314 (2017)
Introduction Algeria is a country of 40.4 million inhabitants and half of which is under 30 years. In Algeria, Health-care insurance covered, 90% of the population. Health care is free and it is supported by the Ministry of Health. 16 university hosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b56b1220cce2e5be77754051a817669
https://doi.org/10.1016/j.hemonc.2017.05.019
https://doi.org/10.1016/j.hemonc.2017.05.019
Autor:
R. Bouhass, Badra Entasoltan, Leila Charef, Mohamed Amine Mazari, Mohamed Amine Bekadja, Amina Krim, Mohamed Brahimi, Kamila Amani, Samira Bouchama, Faiza Serradj, Abdessamed Arabi, Soufi Osmani, Souad Talhi, Nabil Yafour
Publikováno v:
Bone Marrow Transplantation. 53:1596-1598
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c9f7da62a4822bb3205def68f9cfc0
https://doi.org/10.1038/s41409-018-0243-0
https://doi.org/10.1038/s41409-018-0243-0
Autor:
Nouri Midoun, N Mehalhal, MT Abad, F Grifi, Noureddine Sidimansour, M Belhani, Hocine Ait-Ali, Fatima Zohra Ardjoun, S Hamdi, Mohamed Amine Bekadja, Rose Marie Hamladji, R. Bouhass, Hadj Touhami, Naima Mesli, Yousuf Mohamed Said, Z Zouaoui, M Saidi, A Bachiri
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 4, Iss 4, Pp 161-166 (2011)
BACKGROUND AND OBJECTIVES In Algeria, the incidence of hematologic malignancies has been difficult to estimate for many years. Today, many hematological centers, including 14 university hospitals, have been developed in the entire north and have usef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dacbbd002fab6ae08a6fae0acab1cc94
http://www.sciencedirect.com/science/article/pii/S1658387611500032
http://www.sciencedirect.com/science/article/pii/S1658387611500032
Autor:
Abdessamed Arabi, R. Bouhass, Mohamed Amine Bekadja, Nabil Yafour, Soufi Osmani, Mohamed Brahimi
Publikováno v:
Transfusion Clinique et Biologique. 20:502-504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a0ef75c7cbef2b7850253d8e8fd0a65
https://doi.org/10.1016/j.tracli.2013.04.109
https://doi.org/10.1016/j.tracli.2013.04.109
Publikováno v:
European Journal of Haematology. 40:350-354
G gamma to A gamma globin ratios, haplotypes at the beta globin gene cluster and the C----T substitution at -158 5' to the G gamma globin gene were studied in three Algerian families that include SS or S-beta(0) thal patients. G gamma to A gamma rati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88d0792d72e734414514c91438b7f335
https://doi.org/10.1111/j.1600-0609.1988.tb00190.x
https://doi.org/10.1111/j.1600-0609.1988.tb00190.x
Autor:
Amine Ma Bekadja, Naima Mesli, Hadj Touhami, Fatiha Mekkous-Touhami, Z Zouaoui, A Bachiri, Asma Hadjeb, Nadia Houti, Tamim Alsuliman, R. Bouhass, Abdessamed Arabi, N Mehalhal
Publikováno v:
Journal of Blood & Lymph.
Introduction: The principal object of this study is to represent - in maximum accuracy- the real status of Hodgkin’s lymphoma in west of Algeria, we think also it serves as an adequate indicator for the epidemiological characteristics of HL patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd958ae58991e7c502be02fc2378f968
https://doi.org/10.4172/2165-7831.1000120
https://doi.org/10.4172/2165-7831.1000120
Autor:
Kamila Amani, Hafida Ouldjeriouat, R. Bouhass, Amina Krim, Soufi Osmani, Souad Talhi, Samira Bouchama, Leila Charef, Nabil Yafour, Mohamed Amine Mazari, Badra Entasoltan, Mohamed Brahimi, Mohamed Amine Bekadja, Abdessamed Arabi
Publikováno v:
Blood. 128:5732-5732
Introduction: Intensive chemotherapy followed by autologous stem cell transplantation (ASCT) is currently the treatment of choice in multiple myeloma (MM). Mobilization of hematopoietic stem cell blood (HSCs) can be achieved either by the combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5fef4b05d038e17eecc8919d40bbc16
https://doi.org/10.1182/blood.v128.22.5732.5732
https://doi.org/10.1182/blood.v128.22.5732.5732
Autor:
Samira Bouchama, Kamila Amani, R. Bouhass, Mohamed Amine Bekadja, Badra Entasoltan, Nabil Yafour, Soufi Osmani, Mohamed Amine Mazari, Amina Krim, Hafida Ouldjeriouat, Mohamed Brahimi, Leila Charef, Souad Talhi, Abdessamed Arabi
Publikováno v:
Blood. 128:5121-5121
INTRODUCTION: Autologous stem cell transplant (ASCT) is the standard of care in transplant-eligible multiple myeloma (MM) patients and is associated witha significant improvement in progression-free survival (PFS), complete remission rates (CR), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c46ca61f81eaea3d59eb9b050bb9816
https://doi.org/10.1182/blood.v128.22.5121.5121
https://doi.org/10.1182/blood.v128.22.5121.5121